Categories AlphaGraphs, Consumer, Earnings

Beyond Meat (BYND) reports Q2 results. Here’s everything you need to know

Beyond Meat, Inc. (NASDAQ: BYND), a pioneer in plant-based meat substitutes, on Monday reported a net loss for the second quarter of 2023 when its revenues declined in double digits.

Beyond Meat Q2 2023 earnings infographic

The company said net revenues declined 30.5% year-over-year to $102.1 million in the June quarter, with sales at the core Retail segment falling sharply. Meanwhile, net loss narrowed to $53.5 million or $0.83 per share in Q2 from $97.1 million or $1.53 per share in the corresponding period of 2022.

For fiscal 2023, the management expects net revenues to be in the range of $360 million to $380 million, representing a decrease of around 14-19% compared to 2022.

Prior Performance

  • Beyond-Meat-Q3-2022-Earnings-Infographic
  • Beyond Meat Q2 2022 Earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight